New Canadian research shows medical cannabis can help with pain, mood and quality of life, but outcomes vary widely by product, dose and patient.
As cannabis policy debates intensify across North America, a newly published Canadian study offers something that has become rare in the medical marijuana conversation: perspective.
The study, published online January 29 in the Canadian Journal of Pain, followed adult patients authorized to use medical cannabis across Canada for 24 weeks, tracking outcomes related to chronic pain, sleep, anxiety, depression and overall quality of life. The results show consistent, measurable improvements across multiple categories. They also show something that often gets lost in cannabis coverage. On average, the improvements were real but modest, the kind of signal clinicians take seriously while still pushing for clearer guidance on products and dosing.
That distinction matters, and it does not undermine cannabis. It grounds it.
Titled Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis, the paper draws on data from the ongoing Medical Cannabis Real-World Evidence study. Participants were adult patients authorized by health care practitioners to use medical cannabis and were able to select from Health Canada-verified products. Outcomes were measured using widely accepted clinical tools, including PROMIS Pain Interference, the Numeric Pain Rating Scale, GAD-7 for anxiety, PHQ-9 for depression and EQ-5D for quality of life.
Across nearly every measure, patients reported improvement. Pain interference scores declined. Anxiety and depression scores dropped. Sleep duration shifted modestly toward healthier ranges. Quality of life improved.
These changes were statistically significant, meaning they were unlikely to be due to chance. They were also real to the patients reporting them. But by week 24, the average changes did not reach the thresholds often used to define a clearly noticeable clinical improvement. That does not mean medical cannabis did not work. …
Read More
Author: High Times / High Times
